I am confused. These 2 drugs tackle cancer hence why no Phase 3 is my guess. Now that PVCT was told to apply for broader FDA approval than just metastatic melanoma i.e. now going for recurrent melanoma does this mean PV-10 is seen in the same light by the FDA? Thoughts please
It's going out the door if you can see it the way I do. Looks like the FDA liked it so much it wanted more people treated with it....thus the broader label. Very good news....in fact its better news than if they were going to get the BTD before on the spot. I'll wait 60 days or so for a better label.